These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30148433)

  • 41. Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study.
    Parisi S; Zanetti A; Carrara G; Scirè CA; Iagnocco A; Filippou G;
    Rheumatology (Oxford); 2023 Apr; 62(4):1485-1492. PubMed ID: 36066434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active Foot Synovitis in Patients With Rheumatoid Arthritis: Unstable Remission Status, Radiographic Progression, and Worse Functional Outcomes in Patients With Foot Synovitis in Apparent Remission.
    Wechalekar MD; Lester S; Hill CL; Lee A; Rischmueller M; Smith MD; Walker JG; Proudman SM
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1616-1623. PubMed ID: 26991415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial.
    Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML
    Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cumulative patient-based disease activity monitoring in rheumatoid arthritis - predicts sustained remission, flare and treatment escalation.
    Leung MH; Choy EHS; Lau CS
    Semin Arthritis Rheum; 2020 Aug; 50(4):749-758. PubMed ID: 32531504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study.
    Brenol CV; da Chakr RM; Andrade NP; Toni M; Laurindo IM; Brenol JC; Xavier RM
    Clin Rheumatol; 2015 Oct; 34(10):1781-5. PubMed ID: 25771853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients.
    Bergstra SA; Allaart CF; Stijnen T; Landewé RBM
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1473-1483. PubMed ID: 27992656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort.
    Chaiamnuay S; Jiemjit S; Songdechaphipat W; Narongroeknawin P; Pakchotanon R; Asavatanabodee P
    Medicine (Baltimore); 2022 Aug; 101(32):e29974. PubMed ID: 35960097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study.
    Chen YL; Lin JZ; Mo YQ; Ma JD; Li QH; Wang XY; Yang ZH; Yan T; Zheng DH; Dai L
    Arthritis Res Ther; 2018 May; 20(1):81. PubMed ID: 29720221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does patients' opinion of remission in rheumatoid arthritis overlap ultrasound "true" remission? - a pilot study.
    Vlad V; Berghea F; Iorgoveanu V; Popescu M; Predeteanu D; Ionescu R
    Med Ultrason; 2018 Aug; 20(3):328-334. PubMed ID: 30167586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of flare following glucocorticoids withdrawal in rheumatoid arthritis patients with continuation of csDMARDs: a real-life study.
    Xie W; Huang H; Zhang Z
    Intern Emerg Med; 2023 Sep; 18(6):1759-1767. PubMed ID: 37418144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presence of ultrasound subclinical synovitis and increment of serum vascular endothelial growth factor in a patient with rheumatoid arthritis achieved in sustained clinical remission by treatment with adalimumab and methotrexate.
    Kawashiri SY; Arima K; Suzuki T; Nakashima Y; Horai Y; Okada A; Tamai M; Nakamura H; Kawakami A
    Mod Rheumatol; 2014 Jul; 24(4):681-4. PubMed ID: 24533548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva).
    Ceccarelli F; Perricone C; Trotta F; Cuomo G; Pellerito R; Bagnato G; Salaffi F; Caporali R; Cutolo M; Galeazzi M; Fiocco U; Lapadula G; Bombardieri S; Bianchi G; Gorla R; Giardina AR; Gallo G; Giardino AM; Valesini G;
    Clin Exp Rheumatol; 2013; 31(3):341-9. PubMed ID: 23380023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
    Vastesaeger N; Kutzbach AG; Amital H; Pavelka K; Lazaro MA; Moots RJ; Wollenhaupt J; Zerbini CA; Louw I; Combe B; Beaulieu A; Schulze-Koops H; Dasgupta B; Fu B; Huyck S; Weng HH; Govoni M; Durez P
    Rheumatology (Oxford); 2016 Aug; 55(8):1466-76. PubMed ID: 27114562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis.
    O'Neil LJ; Hu P; Liu Q; Islam MM; Spicer V; Rech J; Hueber A; Anaparti V; Smolik I; El-Gabalawy HS; Schett G; Wilkins JA
    Front Immunol; 2021; 12():729681. PubMed ID: 34867950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
    Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study.
    Sekiguchi M; Fujii T; Matsui K; Murakami K; Morita S; Ohmura K; Kawahito Y; Nishimoto N; Mimori T; Sano H;
    J Rheumatol; 2016 Nov; 43(11):1974-1983. PubMed ID: 27585689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.
    Yu C; Li M; Duan X; Fang Y; Li Q; Wu R; Liu S; Wang Y; Wu Z; Shi X; Jiang Z; Wang Y; Hsieh ED; Jin S; Jiang N; Wang Q; Zhao Y; Tian X; Zeng X;
    Clin Exp Rheumatol; 2018; 36(5):836-840. PubMed ID: 29600939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sirolimus selectively increases circulating Treg cell numbers and restores the Th17/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic drugs.
    Niu HQ; Li ZH; Zhao WP; Zhao XC; Zhang C; Luo J; Lu XC; Gao C; Wang CH; Li XF
    Clin Exp Rheumatol; 2020; 38(1):58-66. PubMed ID: 31074719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.